Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
EBAC European Biotech Acquisition
10.1700.0000.00%
Close
02/08 16:00 ET
10.160-0.010-0.10%
Post Mkt Price 02/08 16:18 ET
High
0.000
Open
10.170
Turnover
32.53K
Low
0.000
Pre Close
10.170
Volume
3.20K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
European Biotech Acquisition Corp. (NASDAQ:EBAC) Sees Large Growth in Short Interest
European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 5,50
European Biotech Acquisition Corp. (NASDAQ:EBAC) Short Interest Update
European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) was the target of a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 11
Arena Capital Advisors LLC CA Reduces Stock Position in European Biotech Acquisition Corp. (NASDAQ:EBAC)
Arena Capital Advisors LLC CA lowered its holdings in shares of European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) by 94.5% in the 2nd quarter, Holdings Channel.com reports. The firm owne
SPAC European Biotech to Merge With Swiss Eye Drug Developer Oculis
Dutch SPAC European Biotech Acquisition Corp. (NASDAQ:EBAC) plans to merge with Swiss eye drug developer Oculis in a deal that estimates the enterprise value of the combined company at around $220M. T
European Biotech Acquisition, Oculis Enter Business Combination Agreement
Short Interest in European Biotech Acquisition Corp. (NASDAQ:EBAC) Rises By 2,112.5%
European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) saw a large increase in short interest in September. As of September 30th, there was short interest totalling 17,700 shares, an increase
European Biotech Acquisition Corp. (NASDAQ:EBAC) Short Interest Down 52.9% in September
European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) was the target of a significant decrease in short interest during the month of September. As of September 15th, there was short interest
Short Interest in European Biotech Acquisition Corp. (NASDAQ:EBAC) Increases By 240.0%
European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) was the recipient of a large increase in short interest during the month of August. As of August 31st, there was short interest totalling
Could The European Biotech Acquisition Corp. (NASDAQ:EBAC) Ownership Structure Tell Us Something Useful?
If you want to know who really controls European Biotech Acquisition Corp. (NASDAQ:EBAC), then you'll have to look at the makeup of its share registry. Insiders often own a large chunk of younger, sma
European Biotech Acquisition Says Receives Expected Notification From Nasdaq Related To Delayed Quarterly Report
European Biotech Acquisition Corp. (the "Company") today announced it received a notice on May 28, 2021 from the Nasdaq Stock Market LLC ("Nasdaq") indicating that as a result of the Company's failure
Company Overview
More
European Biotech Acquisition Corp. is a blank check company which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on January 8, 2021 and is headquartered in Lausanne, Switzerland.
CEO： Mr. Eduardo Bravo Fernández de Araoz
Market： NASDAQ
Listing Date： 03/16/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet